Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs.
Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs.
复制标题
DOI:
10.1016/j.vaccine.2014.01.043
复制
发表时间:
2014-03-26
期刊:
影响因子:
5.5
通讯作者:
Schnell, Matthias J.
中科院分区:
文献类型:
--
作者:
McGettigan, James P.;David, Frederic;Figueiredo, Monica Dias;Minke, Jules;Mebatsion, Teshome;Schnell, Matthias J.
Dogs account for the majority of human exposures and deaths due to rabies virus (RABV) worldwide. In this report, we show that a replication-deficient RABV-based vaccine in which the matrix gene is deleted (RABV- M) is safe and induces rapid and potent VNA titers after a single inoculation in dogs. Average VNA titers peaked at 3.02 or 5.11 International Units (IU/ml) by 14 days post-immunization with a single dose of 106 or 107 focus forming units (ffu), respectively, of RABV- M. By day 70 post immunization, all dogs immunized with either dose of vaccine showed VNA titers >0.5 IU/ml, the level indicative of a satisfactory immunization. Importantly, no systemic or local reactions were noted in any dog immunized with RABV- M. The elimination of dog rabies through mass vaccination is hindered by limited resources, requirement for repeat vaccinations often for the life of a dog, and in some parts of the world, inferior vaccine quality. Our preliminary safety and immunogenicity data in dogs suggest that RABV- M might complement currently used inactivated RABV-based vaccines in vaccination campaigns by helping to obtain 100% response in vaccinated dogs, thereby increasing overall vaccination coverage.
登录
查看更多内容
影响因子:
3.8
作者:
Dorfmeier CL;Tzvetkov EP;Gatt A;McGettigan JP
通讯作者:
McGettigan JP
影响因子:
3.8
作者:
Ertl HC
通讯作者:
Ertl HC
影响因子:
11.8
作者:
Duerr, Salome;Meltzer, Martin I.;Zinsstag, Jakob
通讯作者:
Zinsstag, Jakob
影响因子:
2.2
作者:
Watanabe, Ippei;Yamada, Kentaro;Nishizono, Akira
通讯作者:
Nishizono, Akira
影响因子:
2.1
作者:
Berndtsson LT;Nyman AK;Rivera E;Klingeborn B
通讯作者:
Klingeborn B